Page last updated: 2024-09-05

lapatinib and Rhabdoid Tumor

lapatinib has been researched along with Rhabdoid Tumor in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chi, SN; Forsyth, P; Jayanthan, A; Lun, X; Narendran, A; Obaid, H; Ruan, Y; Singh, A; Smith, A; Strother, D	1

Other Studies

1 other study(ies) available for lapatinib and Rhabdoid Tumor

Article	Year
Profiling pathway-specific novel therapeutics in preclinical assessment for central nervous system atypical teratoid rhabdoid tumors (CNS ATRT): favorable activity of targeting EGFR- ErbB2 signaling with lapatinib. Molecular oncology, 2013, Volume: 7, Issue:3 Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Movement; Cell Survival; Cells, Cultured; Central Nervous System Neoplasms; Child; ErbB Receptors; Female; Humans; Infant; Lapatinib; Male; Mice; Molecular Targeted Therapy; Quinazolines; Receptor, ErbB-2; Rhabdoid Tumor; Signal Transduction	2013

Article

Year

Profiling pathway-specific novel therapeutics in preclinical assessment for central nervous system atypical teratoid rhabdoid tumors (CNS ATRT): favorable activity of targeting EGFR- ErbB2 signaling with lapatinib.

Molecular oncology, 2013, Volume: 7, Issue:3

Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Movement; Cell Survival; Cells, Cultured; Central Nervous System Neoplasms; Child; ErbB Receptors; Female; Humans; Infant; Lapatinib; Male; Mice; Molecular Targeted Therapy; Quinazolines; Receptor, ErbB-2; Rhabdoid Tumor; Signal Transduction

2013